Rifaquin Trial. High-Dose Rifapentine with Moxifoxacin for Pulmonary Tuberculosis (Rifaquin)
dataset
posted on 2024-11-25, 12:15 authored by Amina JindaniAmina Jindani, Thomas S. Harrison, Andrew J. Nunn, Patrick P.J. Phillips, Gavin J. Churchyard, Salome Charalambous, Mark Hatherill, Hennie Geldenhuys, Helen M. McIlleron, Simbarashe P. Zvada, Stanley Mungofa, Nasir A. Shah, Simukai Zizhou, Lloyd Magweta, James Shepherd, Sambayawo Nyirenda, Janneke H. van Dijk, Heather E. Clouting, David Coleman, Anna L.E. Bateson, Timothy D McHugh, Philip D Butcher, Denny A. MitchisonThe 6-month regimen that included weekly administration of high-dose rifapentine and moxifloxacin was as effective as the control regimen. The 4-month regimen was not noninferior to the control regimen.
History
Research Institute
- Infection and Immunity
